Patients undergoing left atrial appendage occlusion (LAAO) with a Watchman device may experience a significantly lower risk of early device-related thrombus (DRT) when managed with low-dose direct oral anticoagulation (LD-DOAC) compared to dual antiplatelet therapy (DAPT).